316 related articles for article (PubMed ID: 15007601)
1. Pregnancy outcomes and menstrual function after fertility sparing surgery for pure ovarian dysgerminomas.
Boran N; Tulunay G; Caliskan E; Köse MF; Haberal A
Arch Gynecol Obstet; 2005 Feb; 271(2):104-8. PubMed ID: 15007601
[TBL] [Abstract][Full Text] [Related]
2. Dysgerminoma: the role of conservative surgery.
Casey AC; Bhodauria S; Shapter A; Nieberg R; Berek JS; Farias-Eisner R
Gynecol Oncol; 1996 Dec; 63(3):352-7. PubMed ID: 8946871
[TBL] [Abstract][Full Text] [Related]
3. Conservative surgery to preserve ovarian function in patients with malignant ovarian germ cell tumors. A review of 74 cases.
Low JJ; Perrin LC; Crandon AJ; Hacker NF
Cancer; 2000 Jul; 89(2):391-8. PubMed ID: 10918171
[TBL] [Abstract][Full Text] [Related]
4. Pure dysgerminoma of the ovary 35 years on: a single institutional experience.
Vicus D; Beiner ME; Klachook S; Le LW; Laframboise S; Mackay H
Gynecol Oncol; 2010 Apr; 117(1):23-6. PubMed ID: 20097412
[TBL] [Abstract][Full Text] [Related]
5. Outcome and reproductive function after cumulative high-dose combination chemotherapy with bleomycin, etoposide and cisplatin (BEP) for patients with ovarian endodermal sinus tumor.
Kang H; Kim TJ; Kim WY; Choi CH; Lee JW; Kim BG; Bae DS
Gynecol Oncol; 2008 Oct; 111(1):106-10. PubMed ID: 18656249
[TBL] [Abstract][Full Text] [Related]
6. [Evaluation of the effect of fertility-saving surgery on young patients with malignant ovarian tumors].
Xi MR; Hou MM; Cao ZY; Zhang CS; Peng ZL; Wang HJ; Zheng A
Zhonghua Fu Chan Ke Za Zhi; 2006 Apr; 41(4):233-6. PubMed ID: 16759456
[TBL] [Abstract][Full Text] [Related]
7. Fertility-sparing surgery for ovarian low malignant potential tumors.
Rao GG; Skinner EN; Gehrig PA; Duska LR; Miller DS; Schorge JO
Gynecol Oncol; 2005 Aug; 98(2):263-6. PubMed ID: 15964063
[TBL] [Abstract][Full Text] [Related]
8. [Ovarian dysgerminoma in children and adolescents. Retrospective clinico-pathologic study].
Zuntová A; Sumerauer D; Teslík L; Koutecký J
Cas Lek Cesk; 2004; 143(4):246-52. PubMed ID: 15218724
[TBL] [Abstract][Full Text] [Related]
9. Surgical management of borderline ovarian tumors: The role of fertility-sparing surgery.
Park JY; Kim DY; Kim JH; Kim YM; Kim YT; Nam JH
Gynecol Oncol; 2009 Apr; 113(1):75-82. PubMed ID: 19171373
[TBL] [Abstract][Full Text] [Related]
10. [Results of fertility preserving operations in malignant ovarian tumors].
Kleine W
Zentralbl Gynakol; 1996; 118(6):317-21. PubMed ID: 8768006
[TBL] [Abstract][Full Text] [Related]
11. Outcome and reproductive function after chemotherapy for ovarian dysgerminoma.
Brewer M; Gershenson DM; Herzog CE; Mitchell MF; Silva EG; Wharton JT
J Clin Oncol; 1999 Sep; 17(9):2670-75. PubMed ID: 10561340
[TBL] [Abstract][Full Text] [Related]
12. Young girls with malignant ovarian germ cell tumors can undergo normal menarche and menstruation after fertility-preserving surgery and adjuvant chemotherapy.
Yoo SC; Kim WY; Yoon JH; Chang SJ; Chang KH; Ryu HS
Acta Obstet Gynecol Scand; 2010; 89(1):126-30. PubMed ID: 19878051
[TBL] [Abstract][Full Text] [Related]
13. Adjuvant therapy of completely resected dysgerminoma with carboplatin and etoposide: a trial of the Gynecologic Oncology Group.
Williams SD; Kauderer J; Burnett AF; Lentz SS; Aghajanian C; Armstrong DK
Gynecol Oncol; 2004 Dec; 95(3):496-9. PubMed ID: 15581952
[TBL] [Abstract][Full Text] [Related]
14. Outcomes of fertility-sparing surgery for invasive epithelial ovarian cancer: oncologic safety and reproductive outcomes.
Park JY; Kim DY; Suh DS; Kim JH; Kim YM; Kim YT; Nam JH
Gynecol Oncol; 2008 Sep; 110(3):345-53. PubMed ID: 18586310
[TBL] [Abstract][Full Text] [Related]
15. Fertility-sparing surgery and outcome in fertile women with ovarian borderline tumors and epithelial invasive ovarian cancer.
Borgfeldt C; Iosif C; Måsbäck A
Eur J Obstet Gynecol Reprod Biol; 2007 Sep; 134(1):110-4. PubMed ID: 16859821
[TBL] [Abstract][Full Text] [Related]
16. Prognostic factors and role of salvage surgery in chemorefractory ovarian germ cell malignancies: a study in Chinese patients.
Li J; Yang W; Wu X
Gynecol Oncol; 2007 Jun; 105(3):769-75. PubMed ID: 17459461
[TBL] [Abstract][Full Text] [Related]
17. Malignant ovarian germ cell tumors: a single-institution experience.
Cicin I; Eralp Y; Saip P; Ayan I; Kebudi R; Iyibozkurt C; Tuzlali S; Gorgun O; Topuz E
Am J Clin Oncol; 2009 Apr; 32(2):191-6. PubMed ID: 19307952
[TBL] [Abstract][Full Text] [Related]
18. [Comprehensive staging surgery in treatment of malignant ovarian germ cell tumor].
Jin Y; Pan LY; Huang HF; Shen K; Wu M; Yang JX; Lang JH
Zhonghua Fu Chan Ke Za Zhi; 2005 Dec; 40(12):826-30. PubMed ID: 16412329
[TBL] [Abstract][Full Text] [Related]
19. Fertility and recurrence results of conservative surgery for borderline ovarian tumors.
Boran N; Cil AP; Tulunay G; Ozturkoglu E; Koc S; Bulbul D; Kose MF
Gynecol Oncol; 2005 Jun; 97(3):845-51. PubMed ID: 15896834
[TBL] [Abstract][Full Text] [Related]
20. Borderline tumors of the ovary: fertility treatment, conservative management, and pregnancy outcome.
Gotlieb WH; Flikker S; Davidson B; Korach Y; Kopolovic J; Ben-Baruch G
Cancer; 1998 Jan; 82(1):141-6. PubMed ID: 9428490
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
